| # | Drug | Count |
|---|---|---|
| 0 | METHYLPREDNISOLONE | 189 |
| 1 | METHOTREXATE SODIUM | 168 |
| 2 | PREDNISONE | 165 |
| 3 | METHOTREXATE | 156 |
| 4 | CYCLOPHOSPHAMIDE | 148 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 148 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 148 |
| 7 | DEXAMETHASONE | 117 |
| 8 | DEXAMETHASONE 1.5 MG | 117 |
| 9 | TACROLIMUS | 109 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAUNORUBICIN HYDROCHLORIDE | 16 | 0.0097 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 59 | 0.0071 |
| 2 | PEGASPARGASE | 75 | 0.0061 |
| 3 | IOPROMIDE | 25 | 0.0060 |
| 4 | MERCAPTOPURINE | 75 | 0.0043 |
| 5 | CALCIUM FOLINATE | 16 | 0.0034 |
| 6 | GRANULOCYTE COLONY STIMULATING FACTOR | 7 | 0.0032 |
| 7 | BASILIXIMAB | 34 | 0.0028 |
| 8 | DAPTOMYCIN | 25 | 0.0026 |
| 9 | BARICITINIB | 8 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 373 |
| 1 | Alkylating Drug [EPC] | 188 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 164 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 160 |
| 4 | Topoisomerase Inhibitor [EPC] | 104 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 94 |
| 6 | Leukocyte Growth Factor [EPC] | 92 |
| 7 | Platinum-based Drug [EPC] | 79 |
| 8 | Asparagine-specific Enzyme [EPC] | 75 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 65 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 75 | 0.0056 |
| 1 | Endoglycosidase [EPC] | 5 | 0.0027 |
| 2 | Lipopeptide Antibacterial [EPC] | 25 | 0.0026 |
| 3 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 23 | 0.0017 |
| 5 | Bile Acid Sequestrant [EPC] | 20 | 0.0016 |
| 6 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 7 | Topoisomerase Inhibitor [EPC] | 104 | 0.0014 |
| 8 | Echinocandin Antifungal [EPC] | 10 | 0.0012 |
| 9 | Radiographic Contrast Agent [EPC] | 27 | 0.0010 |